ORBIMED ADVISORS LLC - 09 May 2025 SCHEDULE 13D/A Report for Edgewise Therapeutics, Inc. Common Stock (EWTX)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
Edgewise Therapeutics, Inc. Common Stock
Symbol
EWTX
Shares outstanding
105,192,186 shares
Disclosed Ownership
15,252,867 shares
Ownership
14%
Form type
SCHEDULE 13D/A
Filing time
12 May 2025, 19:13:03 UTC
Date of event
09 May 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 14% 15,252,867 0 15,252,867 /s/ Carl L. Gordon Carl L. Gordon/Member 0001055951
ORBIMED CAPITAL GP VI LLC 14% 14,809,075 0 14,809,075 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC (ORBIMED ADVISORS LLC, its managing member) 0001682115
OrbiMed Genesis GP LLC 0.4% 443,792 0 443,792 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC (ORBIMED ADVISORS LLC, its managing member) 0001808744
ORBIMED CAPITAL LLC 0.3% 265,625 265,625 0 /s/ Carl L. Gordon Carl L. Gordon/Member 0001157524